Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

О Lite Strategy

Основано2018

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Сообщество
Twitter
Website
Тэги
Publicly listed company
Crypto Stocks

Тенденция изменения индекса Горячих проектов

Подробности сбора средств

Post-IPO(2025-07-21)
Сумма₽8,01B
Оценка--